Does the media prefer CNMD or MMSI?

In the previous week, CONMED had 1 more articles in the media than Merit Medical Systems. MarketBeat recorded 4 mentions for CONMED and 3 mentions for Merit Medical Systems. CONMED's average media sentiment score of 0.51 beat Merit Medical Systems' score of 0.48 indicating that CONMED is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor CNMD or MMED?

In the previous week, MiniMed Group had 8 more articles in the media than CONMED. MarketBeat recorded 12 mentions for MiniMed Group and 4 mentions for CONMED. CONMED's average media sentiment score of 0.51 beat MiniMed Group's score of 0.34 indicating that CONMED is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MiniMed Group 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger earnings & valuation, TFX or CNMD?

CONMED has lower revenue, but higher earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Teleflex $1.99B 2.66 -$905.64M -$23.29 N/A CONMED $1.37B 0.97 $47.06M $1.85 24.02

Is TFX or CNMD more profitable?

CONMED has a net margin of 4.12% compared to Teleflex's net margin of -39.67%. CONMED's return on equity of 14.31% beat Teleflex's return on equity. Company Net Margins Return on Equity Return on Assets Teleflex -39.67% 11.93% 5.44% CONMED 4.12% 14.31% 6.33%

Does the media refer more to TFX or CNMD?

In the previous week, CONMED had 1 more articles in the media than Teleflex. MarketBeat recorded 4 mentions for CONMED and 3 mentions for Teleflex. CONMED's average media sentiment score of 0.51 beat Teleflex's score of 0.00 indicating that CONMED is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teleflex 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CONMED 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is HAE or CNMD more profitable?

Haemonetics has a net margin of 7.12% compared to CONMED's net margin of 4.12%. Haemonetics' return on equity of 27.55% beat CONMED's return on equity. Company Net Margins Return on Equity Return on Assets Haemonetics 7.12% 27.55% 9.65% CONMED 4.12% 14.31% 6.33%

Does the media refer more to HAE or CNMD?

In the previous week, Haemonetics had 15 more articles in the media than CONMED. MarketBeat recorded 19 mentions for Haemonetics and 4 mentions for CONMED. CONMED's average media sentiment score of 0.51 beat Haemonetics' score of 0.48 indicating that CONMED is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Haemonetics 6 Very Positive mention(s) 3 Positive mention(s) 9 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral CONMED 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, CNMD or ITGR?

Integer has higher revenue and earnings than CONMED. CONMED is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CONMED $1.37B 0.97 $47.06M $1.85 24.02 Integer $1.85B 2.32 $102.81M $3.66 34.60

Is CNMD or ITGR more profitable?

Integer has a net margin of 6.97% compared to CONMED's net margin of 4.12%. CONMED's return on equity of 14.31% beat Integer's return on equity. Company Net Margins Return on Equity Return on Assets CONMED 4.12% 14.31% 6.33% Integer 6.97% 12.79% 6.48%

Does the media favor CNMD or ITGR?

In the previous week, Integer had 1 more articles in the media than CONMED. MarketBeat recorded 5 mentions for Integer and 4 mentions for CONMED. CONMED's average media sentiment score of 0.51 beat Integer's score of 0.18 indicating that CONMED is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integer 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

CONMED (CNMD) Competitors

$44.43 -0.68 (-1.51%)

Closing price 10/9/2026 03:59 PM Eastern

Extended Trading

$44.44 +0.01 (+0.03%)

As of 10/9/2026 07:32 PM Eastern

Compare

CNMD vs. MMSI, MMED, TFX, HAE, and ITGR

Should you buy CONMED stock or one of its competitors? CONMED's main competitors and comparable companies include Merit Medical Systems (MMSI), MiniMed Group (MMED), Teleflex (TFX), Haemonetics (HAE), and Integer (ITGR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment & supplies" industry.

How does CONMED compare to Merit Medical Systems?

CONMED (NYSE:CNMD) and Merit Medical Systems (NASDAQ:MMSI) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, analyst recommendations, earnings, profitability, dividends and valuation.

99.7% of Merit Medical Systems shares are owned by institutional investors. 0.3% of CONMED shares are owned by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

CONMED has a beta of 0.94, indicating that its share price is 6% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.51, indicating that its share price is 49% less volatile than the broader market.

In the previous week, CONMED had 1 more articles in the media than Merit Medical Systems. MarketBeat recorded 4 mentions for CONMED and 3 mentions for Merit Medical Systems. CONMED's average media sentiment score of 0.51 beat Merit Medical Systems' score of 0.48 indicating that CONMED is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CONMED	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Merit Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Merit Medical Systems has a net margin of 9.22% compared to CONMED's net margin of 4.12%. CONMED's return on equity of 14.31% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	4.12%	14.31%	6.33%
Merit Medical Systems	9.22%	13.75%	8.10%

Merit Medical Systems has higher revenue and earnings than CONMED. CONMED is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.37B	0.97	$47.06M	$1.85	24.02
Merit Medical Systems	$1.52B	3.44	$128.49M	$2.42	36.04

CONMED currently has a consensus target price of $41.40, suggesting a potential downside of 6.82%. Merit Medical Systems has a consensus target price of $100.00, suggesting a potential upside of 14.67%. Given Merit Medical Systems' stronger consensus rating and higher possible upside, analysts clearly believe Merit Medical Systems is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	2 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.75
Merit Medical Systems	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.83

Summary

Merit Medical Systems beats CONMED on 13 of the 17 factors compared between the two stocks.

How does CONMED compare to MiniMed Group?

CONMED (NYSE:CNMD) and MiniMed Group (NASDAQ:MMED) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, media sentiment, earnings and analyst recommendations.

CONMED has higher earnings, but lower revenue than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.37B	0.97	$47.06M	$1.85	24.02
MiniMed Group	$3.10B	1.79	-$333M	-$0.68	N/A

CONMED currently has a consensus target price of $41.40, indicating a potential downside of 6.82%. MiniMed Group has a consensus target price of $24.00, indicating a potential upside of 21.77%. Given MiniMed Group's stronger consensus rating and higher possible upside, analysts plainly believe MiniMed Group is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	2 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.75
MiniMed Group	1 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.71

In the previous week, MiniMed Group had 8 more articles in the media than CONMED. MarketBeat recorded 12 mentions for MiniMed Group and 4 mentions for CONMED. CONMED's average media sentiment score of 0.51 beat MiniMed Group's score of 0.34 indicating that CONMED is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CONMED	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
MiniMed Group	2 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

CONMED has a net margin of 4.12% compared to MiniMed Group's net margin of 0.00%. CONMED's return on equity of 14.31% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	4.12%	14.31%	6.33%
MiniMed Group	N/A	N/A	N/A

Summary

CONMED beats MiniMed Group on 7 of the 13 factors compared between the two stocks.

How does CONMED compare to Teleflex?

Teleflex (NYSE:TFX) and CONMED (NYSE:CNMD) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations.

95.6% of Teleflex shares are held by institutional investors. 0.7% of Teleflex shares are held by insiders. Comparatively, 0.3% of CONMED shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, CONMED had 1 more articles in the media than Teleflex. MarketBeat recorded 4 mentions for CONMED and 3 mentions for Teleflex. CONMED's average media sentiment score of 0.51 beat Teleflex's score of 0.00 indicating that CONMED is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teleflex	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CONMED	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CONMED has a net margin of 4.12% compared to Teleflex's net margin of -39.67%. CONMED's return on equity of 14.31% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teleflex	-39.67%	11.93%	5.44%
CONMED	4.12%	14.31%	6.33%

Teleflex has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market. Comparatively, CONMED has a beta of 0.94, suggesting that its share price is 6% less volatile than the broader market.

CONMED has lower revenue, but higher earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teleflex	$1.99B	2.66	-$905.64M	-$23.29	N/A
CONMED	$1.37B	0.97	$47.06M	$1.85	24.02

Teleflex presently has a consensus target price of $155.20, indicating a potential upside of 24.15%. CONMED has a consensus target price of $41.40, indicating a potential downside of 6.82%. Given Teleflex's stronger consensus rating and higher probable upside, equities analysts clearly believe Teleflex is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teleflex	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.67
CONMED	2 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.75

Summary

CONMED beats Teleflex on 9 of the 17 factors compared between the two stocks.

How does CONMED compare to Haemonetics?

Haemonetics (NYSE:HAE) and CONMED (NYSE:CNMD) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations.

Haemonetics has a net margin of 7.12% compared to CONMED's net margin of 4.12%. Haemonetics' return on equity of 27.55% beat CONMED's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Haemonetics	7.12%	27.55%	9.65%
CONMED	4.12%	14.31%	6.33%

Haemonetics has higher earnings, but lower revenue than CONMED. CONMED is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Haemonetics	$1.35B	4.00	$97.31M	$2.04	58.26
CONMED	$1.37B	0.97	$47.06M	$1.85	24.02

Haemonetics has a beta of 0.61, suggesting that its stock price is 39% less volatile than the broader market. Comparatively, CONMED has a beta of 0.94, suggesting that its stock price is 6% less volatile than the broader market.

99.7% of Haemonetics shares are held by institutional investors. 2.1% of Haemonetics shares are held by insiders. Comparatively, 0.3% of CONMED shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Haemonetics currently has a consensus target price of $110.00, indicating a potential downside of 7.45%. CONMED has a consensus target price of $41.40, indicating a potential downside of 6.82%. Given CONMED's higher possible upside, analysts plainly believe CONMED is more favorable than Haemonetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Haemonetics	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
CONMED	2 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.75

In the previous week, Haemonetics had 15 more articles in the media than CONMED. MarketBeat recorded 19 mentions for Haemonetics and 4 mentions for CONMED. CONMED's average media sentiment score of 0.51 beat Haemonetics' score of 0.48 indicating that CONMED is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Haemonetics	6 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
CONMED	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Haemonetics beats CONMED on 13 of the 17 factors compared between the two stocks.

How does CONMED compare to Integer?

CONMED (NYSE:CNMD) and Integer (NYSE:ITGR) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, profitability, analyst recommendations, valuation and media sentiment.

99.3% of Integer shares are owned by institutional investors. 0.3% of CONMED shares are owned by insiders. Comparatively, 1.1% of Integer shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

CONMED has a beta of 0.94, indicating that its share price is 6% less volatile than the broader market. Comparatively, Integer has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market.

In the previous week, Integer had 1 more articles in the media than CONMED. MarketBeat recorded 5 mentions for Integer and 4 mentions for CONMED. CONMED's average media sentiment score of 0.51 beat Integer's score of 0.18 indicating that CONMED is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CONMED	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integer	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

CONMED currently has a consensus price target of $41.40, indicating a potential downside of 6.82%. Integer has a consensus price target of $109.86, indicating a potential downside of 13.25%. Given CONMED's higher possible upside, equities analysts clearly believe CONMED is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	2 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.75
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07

Integer has higher revenue and earnings than CONMED. CONMED is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.37B	0.97	$47.06M	$1.85	24.02
Integer	$1.85B	2.32	$102.81M	$3.66	34.60

Integer has a net margin of 6.97% compared to CONMED's net margin of 4.12%. CONMED's return on equity of 14.31% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	4.12%	14.31%	6.33%
Integer	6.97%	12.79%	6.48%

Summary

Integer beats CONMED on 12 of the 16 factors compared between the two stocks.

Get CONMED News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CNMD vs. The Competition

Export

Metric	CONMED	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$1.35B	$5.44B	$7.16B	$22.94B
Dividend Yield	N/A	1.78%	2.53%	3.72%
P/E Ratio	24.02	25.57	274.15	28.60
Price / Sales	0.97	83.27	590.50	15.23
Price / Cash	6.26	31.87	76.38	37.72
Price / Book	1.33	5.93	11.21	4.72
Net Income	$47.06M	$146.18M	$3.50B	$1.07B
7 Day Performance	-4.13%	-0.38%	-0.90%	0.35%
1 Month Performance	-3.62%	-2.02%	-4.44%	-2.93%
1 Year Performance	4.32%	5.08%	6.96%	9.26%

CONMED Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CNMD CONMED	2.052 of 5 stars	$44.43 -1.5%	$41.40 -6.8%	-2.2%	$1.35B	$1.37B	24.02	3,900	News Coverage Analyst Downgrade Gap Up
MMSI Merit Medical Systems	3.6475 of 5 stars	$86.37 -0.9%	$100.00 +15.8%	+5.7%	$5.21B	$1.52B	36.03	7,500	Positive News
MMED MiniMed Group	2.2057 of 5 stars	$19.79 -1.9%	$24.14 +22.0%	N/A	$5.59B	$3.10B	N/A	2,800	News Coverage Analyst Forecast Options Volume
TFX Teleflex	4.1165 of 5 stars	$124.21 -0.8%	$155.20 +25.0%	+0.2%	$5.32B	$1.99B	N/A	15,500
HAE Haemonetics	2.4141 of 5 stars	$104.65 0.0%	$99.78 -4.7%	+137.4%	$4.79B	$1.33B	51.60	3,009	Trending News Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CNMD) was last updated on 10/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CONMED (CNMD) Competitors

CNMD vs. MMSI, MMED, TFX, HAE, and ITGR

How does CONMED compare to Merit Medical Systems?

Summary

How does CONMED compare to MiniMed Group?

Summary

How does CONMED compare to Teleflex?

Summary

How does CONMED compare to Haemonetics?

Summary

How does CONMED compare to Integer?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNMD vs. The Competition

CONMED Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CONMED (CNMD) Competitors

CNMD vs. MMSI, MMED, TFX, HAE, and ITGR

How does CONMED compare to Merit Medical Systems?

Do institutionals & insiders have more ownership in CNMD or MMSI?

Which has more volatility & risk, CNMD or MMSI?

Does the media prefer CNMD or MMSI?

Is CNMD or MMSI more profitable?

Which has preferable earnings and valuation, CNMD or MMSI?

Do analysts recommend CNMD or MMSI?

Summary

How does CONMED compare to MiniMed Group?

Which has higher earnings & valuation, CNMD or MMED?

Do analysts rate CNMD or MMED?

Does the media favor CNMD or MMED?

Is CNMD or MMED more profitable?

Summary

How does CONMED compare to Teleflex?

Do insiders and institutionals believe in TFX or CNMD?

Does the media refer more to TFX or CNMD?

Is TFX or CNMD more profitable?

Which has more risk & volatility, TFX or CNMD?

Which has stronger earnings & valuation, TFX or CNMD?

Do analysts prefer TFX or CNMD?

Summary

How does CONMED compare to Haemonetics?

Is HAE or CNMD more profitable?

Which has better valuation & earnings, HAE or CNMD?

Which has more risk and volatility, HAE or CNMD?

Do insiders & institutionals believe in HAE or CNMD?

Do analysts prefer HAE or CNMD?

Does the media refer more to HAE or CNMD?

Summary

How does CONMED compare to Integer?

Do insiders and institutionals believe in CNMD or ITGR?

Which has more volatility and risk, CNMD or ITGR?

Does the media favor CNMD or ITGR?

Do analysts prefer CNMD or ITGR?

Which has stronger valuation & earnings, CNMD or ITGR?

Is CNMD or ITGR more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNMD vs. The Competition

CONMED Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools